Cardiac T2* Magnetic Resonance can cut Thalassaemia deaths

Researchers at the Royal Brompton Hospital and Imperial College London have shown that Cardiac T2* Magnetic Resonance imaging can reduce the risk of dying in individuals with Thalassaemia

Researchers at the Royal Brompton Hospital and Imperial College London have shown that Cardiac T2* Magnetic Resonance imaging can reduce the risk of dying in individuals with Thalassaemia. The study was published this month in Circulation (published online before print October 2, 2009, doi: 10.1161/CIRCULATIONAHA.109.874487) and featured in Times Online 

The study was led by Dudley Pennell, Professor of Cardiology at the National Heart and Lung Institute and Director of the National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Unit (BRU) at the Royal Brompton Hospital. Professor Pennell is also the lead investigator of the Cardiac Imaging research theme within the BHF Centre at Imperial College London.